T/CI 379-2024 Active Group standards

T/CI 379-2024 The method for quickly monitoring the blood concentration of escitalopram

Publish Date: 2024-06-06 Implement Date: 2024-06-06 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CI 379-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Standardized management and general provisions

ICS Name: Terminology (principles and coordination and cooperation)

Publish Date: 2024-06-06

Implement Date: 2024-06-06

Scope

Scope: This document specifies the principles, reagents and materials, instrumentation, samples, solution preparation, and monitoring steps for rapid monitoring of the blood drug concentration of Duloxetine Hydrochloride using a two-dimensional liquid chromatograph system. This document is applicable to the rapid monitoring of the blood drug concentration of Duloxetine Hydrochloride in plasma using a two-dimensional liquid chromatograph system; Main technical content: This document specifies the principles, reagents and materials, instrumentation, samples, solution preparation, and monitoring steps for rapid monitoring of the blood drug concentration of Duloxetine Hydrochloride using a two-dimensional liquid chromatograph system. This document is applicable to the rapid monitoring of the blood drug concentration of Duloxetine Hydrochloride in plasma using a two-dimensional liquid chromatograph system.